BPC-157 and TB-500 (Ac-LKKTETQ) Interaction
BPC-157 and TB-500 (Ac-LKKTETQ) have a synergistic interaction with 95% confidence. Commonly combined for enhanced healing effects through different mechanisms. Both compounds affect the blood vessels, so monitoring these systems is recommended.
Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
View full profileTB-500 (Ac-LKKTETQ)
Thymosin Beta-4 Active Fragment | Healing Peptide
TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with TB-500 (Ac-LKKTETQ)?
Yes, BPC-157 and TB-500 (Ac-LKKTETQ) can generally be taken together. Commonly combined for enhanced healing effects through different mechanisms.
Is BPC-157 and TB-500 (Ac-LKKTETQ) safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and TB-500 (Ac-LKKTETQ)?
Commonly combined for enhanced healing effects through different mechanisms. This assessment has 95% confidence and is based on documented research data.
How should I time BPC-157 and TB-500 (Ac-LKKTETQ)?
BPC-157 has a half-life of <30 minutes and TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.